Targeting CD37-positive lymphoid malignancies with a novel engineered small modular immunopharmaceutical. [electronic resource]
Producer: 20071106Description: 2569-77 p. digitalISSN:- 0006-4971
- Animals
- Antibodies, Neoplasm -- immunology
- Antibody-Dependent Cell Cytotoxicity -- immunology
- Antigens, CD -- genetics
- Antigens, CD19 -- metabolism
- Antigens, Neoplasm -- genetics
- Apoptosis
- Caspases -- metabolism
- Enzyme Activation
- Humans
- Killer Cells, Natural -- immunology
- Leukemia, Lymphocytic, Chronic, B-Cell -- drug therapy
- Mice
- Mice, SCID
- Tetraspanins
- Tumor Cells, Cultured
- Xenograft Model Antitumor Assays
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.